BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Translate Bio Names John R. Schroer, CFA, Chief Financial Officer

  Mr. Schroer brings expertise in financial strategy and analysis and strong industry relationships to Translate Bio.

  May 23, 2018

   · 

  2 min read
• Pharm Country

  Cognition Therapeutics Receives $6.6M in NIA Grants for Two Studies of Elayta™ to Expand Understanding of Synaptoprotective Mechanism of Action

  Cognition Therapeutics Inc.,today announced the receipt of two multi-year grants totaling $6.6 million.

  May 23, 2018

   · 

  5 min read
• Drug Development

  GamaMabs Pharma to present at 2018 ASCO Annual Meeting results from the First-In-Human clinical study of GM102 in advanced gynecological cancers

  GamaMabs Pharma announces the upcoming presentation of clinical data from the First-In-Human C101 phase Ia/Ib study of its GM102 antibody during the American Society of Clinical Oncology (ASCO) Annual Meeting, on June 4 in Chicago, USA.

  May 23, 2018

   · 

  3 min read
• MedAlliance Raises $37 Million to Launch Sirolimus Drug-Coated Balloon

  M.A. MedAlliance SA has raised $37 million.

  May 23, 2018

   · 

  3 min read
• Presentation of New Data on MDxHealth’s Prostate and Bladder Cancer Products at AUA 2018 Annual Meeting

  MDxHealth SA announces that significant data on the performance of its SelectMDx, and ConfirmMDx tests for prostate cancer and AssureMDx test for bladder cancer were presented in two moderated posters and one podium presentation at the American Urological (AUA) Annual Meeting 18-21 May in San Francisco.

  May 23, 2018

   · 

  4 min read
• BioForest

  Achieve Life Sciences, Inc. Announces Reverse Stock Split

  Reverse stock split of its shares of common stock at a ratio of 1-for-10.

  May 23, 2018

   · 

  4 min read
• Business

  LogicBio Therapeutics Appoints Dean Falb, Ph.D., as Chief Scientific Officer

  Genome editing company adds drug development expert in pursuit of breakthrough medicines for pediatric patients

  May 23, 2018

   · 

  2 min read
• FDA

  BERG Announces FDA Orphan-Drug Designation of BPM 31510 for the Treatment of Patients with Epidermolysis Bullosa

  Epidermolysis Bullosa is a rare, pervasive and debilitating connective tissue disorder for which there is currently no FDA-approved treatment or cure.

  May 23, 2018

   · 

  4 min read
• Business

  Berkeley Lights and TPG Biologics Enter into a Strategic Collaboration for Cell Line Development

  Program Implements Beacon Platform for Creating Workflow Efficiencies to Accelerate the Drug Development Process

  May 23, 2018

   · 

  3 min read
• FDA

  FDA Grants Breakthrough Therapy Designation to Lenti-D™ for the Treatment of Cerebral Adrenoleukodystrophy

  Cerebral adrenoleukodystrophy is a rare, serious and life-threatening hereditary neurological disorder.

  May 23, 2018

   · 

  7 min read